| Literature DB >> 35437918 |
Joshua A Thia1, Xuan Cheng1, James Maino2, Paul A Umina1,2, Ary A Hoffmann1.
Abstract
BACKGROUND: Quantifying how chemical tolerance of pest arthropods varies with temperature is important for understanding the outcomes of chemical control, for measuring and monitoring resistance, and for predicting how pesticide resistance will evolve under future climate change. We studied the redlegged earth mite, Halotydeus destructor (Tucker), a winter-active invasive agricultural pest in Australia. Using a replicated block experiment, we tested the effect of different thermal conditions on the expression of chemical tolerance to a pyrethroid and two organophosphates. Our chemical bioassays were conducted on two redlegged earth mite populations: one possessed organophosphate resistance, whilst the other was susceptible to pesticides. Mites were first acclimated at cool (4 °C) and warm (14 °C) conditions and then exposed to pesticides in both cool (11 °C) and warm (18 °C) test conditions.Entities:
Keywords: Australia; organophosphates; pesticide resistance; pyrethroids; redlegged earth mites; temperature dependence
Mesh:
Substances:
Year: 2022 PMID: 35437918 PMCID: PMC9325430 DOI: 10.1002/ps.6933
Source DB: PubMed Journal: Pest Manag Sci ISSN: 1526-498X Impact factor: 4.462
Figure 1Estimated LD50 values for each active ingredient. The x‐axis separates the acclimation conditions with the log10(LD50) values on the y‐axis. Points with standard errors are coloured by test temperature (see legend). Panels contain the different populations, OP‐Res on the left, and OP‐Sus on the right.
Effects for best fit dose–response generalized linear models (GLMs)
| Active ingredient | Population | Term |
| DF |
|
|---|---|---|---|---|---|
| Bifenthrin | OP‐Res |
| 0.27 | 1 | 0.603 |
|
| 8.96 | 1 | 0.003 * | ||
|
| 66.64 | 1 | <0.001 * | ||
|
| 94 | ||||
| OP‐Sus |
| 6.07 | 1 | 0.014 ~ | |
|
| 3.44 | 1 | 0.064 | ||
|
| 228.23 | 1 | <0.001 * | ||
|
| 0.29 | 1 | 0.591 | ||
|
| 2.56 | 1 | 0.110 | ||
|
| 9.40 | 1 | 0.002 * | ||
|
| 94 | ||||
| Chlorpyrifos | OP‐Res |
| 0.16 | 1 | 0.690 |
|
| 4.99 | 1 | 0.026 ~ | ||
|
| 137.25 | 1 | <0.001 * | ||
|
| 94 | ||||
| OP‐Sus |
| 0.96 | 1 | 0.328 | |
|
| 17.21 | 1 | <0.001 * | ||
|
| 68.62 | 1 | <0.001 * | ||
|
| 0.00 | 1 | 0.967 | ||
|
| 9.98 | 1 | 0.002 * | ||
|
| 2.35 | 1 | 0.125 | ||
|
| 94 | ||||
| Omethoate | OP‐Res |
| 5.04 | 1 | 0.025 ~ |
|
| 7.24 | 1 | 0.007 * | ||
|
| 115.14 | 1 | <0.001 * | ||
|
| 0.51 | 1 | 0.473 | ||
|
| 1.49 | 1 | 0.222 | ||
|
| 0.53 | 1 | 0.467 | ||
|
| 4.13 | 1 | 0.042 ~ | ||
|
| 94 | ||||
| OP‐Sus |
| 1.09 | 1 | 0.295 | |
|
| 7.40 | 1 | 0.007 * | ||
|
| 129.39 | 1 | <0.001 * | ||
|
| 94 |
Significance following a Bonferroni correction for six families of statistical tests (three actives × two populations) is marked with an asterisk, that is, α < 0.0083 (<0.05/6). Significance at α < 0.05 is marked with a tilde.
Dose–response summary statistics
| Population | Active ingredient | Acclimation treatment | Test treatment | Intercept (SE)a | Slope (SE)a | LD50 (95% CI)b |
|
|
|---|---|---|---|---|---|---|---|---|
| Bifenthrin | OP‐Res | Acclim cool | Test cool | 2.08 (±0.97) | 4.48 (±0.85) | 0.34 (0.14–0.82) | 2.31 (3) | 0.510 |
| Test warm | 3.08 (±0.42) | 4.4 (±0.55) | 0.2 (0.16–0.25) | 2.21 (2) | 0.331 | |||
| Acclim warm | Test cool | 1.59 (±0.44) | 3.76 (±0.55) | 0.38 (0.24–0.6) | 4.85 (4) | 0.303 | ||
| Test warm | 2.1 (±0.31) | 2.56 (±0.36) | 0.15 (0.1–0.22) | 9.25 (3) | 0.026 | |||
| OP‐Sus | Acclim cool | Test cool | 3.11 (±0.91) | 5.67 (±1.08) | 0.28 (0.16–0.51) | 1.25 (3) | 0.742 | |
| Test warm | 5.23 (±1.16) | 8.47 (±1.81) | 0.24 (0.18–0.33) | 0.93 (2) | 0.628 | |||
| Acclim warm | Test cool | 4.91 (±1.23) | 7.66 (±1.82) | 0.23 (0.16–0.33) | 1.81 (3) | 0.613 | ||
| Test warm | 5.61 (±0.92) | 7.69 (±1.07) | 0.19 (0.15–0.23) | 35.98 (2) | <0.001 * | |||
| Chlorpyrifos | OP‐Res | Acclim cool | Test cool | −2.09 (±0.45) | 1.18 (±0.19) | 59.85 (17.88–200.41) | 3.38 (3) | 0.336 |
| Test warm | −1.53 (±0.22) | 1.18 (±0.13) | 20.05 (10.71–37.57) | 3.54 (3) | 0.315 | |||
| Acclim warm | Test cool | −2.22 (±0.44) | 1.2 (±0.16) | 70.74 (20.01–250.09) | 1.23 (3) | 0.745 | ||
| Test warm | −1.4 (±0.21) | 1.02 (±0.11) | 23.21 (11.85–45.47) | 3.81 (3) | 0.283 | |||
| OP‐Sus | Acclim cool | Test cool | 1.89 (±1.95) | 4.46 (±1.35) | 0.38 (0.06–2.35) | 71.8 (3) | <0.001 * | |
| Test warm | 3.28 (±2.34) | 3.35 (±0.81) | 0.11 (0.01–2.11) | 52.03 (3) | <0.001 * | |||
| Acclim warm | Test cool | 1.98 (±1.92) | 5.72 (±0.98) | 0.45 (0.1–1.96) | 3.09 (3) | 0.379 | ||
| Test warm | 2.8 (±1.29) | 3.61 (±0.67) | 0.17 (0.04–0.74) | 4.85 (3) | 0.183 | |||
| Omethoate | OP‐Res | Acclim cool | Test cool | −1.53 (±0.25) | 2.65 (±0.44) | 3.79 (2.47–5.81) | 0.13 (3) | 0.988 |
| Test warm | −0.86 (±0.59) | 2 (±0.34) | 2.7 (0.74–9.83) | 3.06 (4) | 0.548 | |||
| Acclim warm | Test cool | −0.92 (±0.21) | 2.04 (±0.31) | 2.83 (1.79–4.48) | 1.32 (3) | 0.726 | ||
| Test warm | 0.04 (±0.32) | 2.88 (±0.47) | 0.97 (0.58–1.61) | 0.12 (3) | 0.990 | |||
| OP‐Sus | Acclim cool | Test cool | 1.85 (±0.81) | 4.55 (±0.83) | 0.39 (0.19–0.81) | 1.88 (2) | 0.391 | |
| Test warm | 1.62 (±0.33) | 3.53 (±0.51) | 0.35 (0.25–0.48) | 0.57 (2) | 0.753 | |||
| Acclim warm | Test cool | 1.41 (±0.32) | 4.64 (±0.64) | 0.5 (0.39–0.63) | 0.36 (2) | 0.834 | ||
| Test warm | 4.68 (±1.69) | 6.5 (±1.06) | 0.19 (0.07–0.54) | 1.68 (2) | 0.431 |
a Log10 (mg L−1).
b In mg L−1.
c Goodness‐of‐fit test statistic and degrees of freedom,
d Goodness‐of‐fit P‐value, with significance at α = 0.05 marked with an asterisk.
Post hoc tests for differences in median lethal dose (LD50) values between cool and warm test treatments
| Active ingredient | Population | Acclimation treatment |
|
| TF b |
|---|---|---|---|---|---|
| Bifenthrin | OP‐Res | Acclim cool | 1.17 | 0.121 | 1.72 |
| Acclim warm | 2.95 | 0.002 * | 2.48 | ||
| OP‐Sus | Acclim cool | 0.47 | 0.321 | 1.17 | |
| Acclim warm | 0.92 | 0.178 | 1.23 | ||
| Chlorpyrifos | OP‐Res | Acclim cool | 1.57 | 0.058 ~ | 2.98 |
| Acclim warm | 1.53 | 0.063 ~ | 3.05 | ||
| OP‐Sus | Acclim cool | 0.71 | 0.239 | 3.57 | |
| Acclim warm | 0.93 | 0.176 | 2.70 | ||
| Omethoate | OP‐Res | Acclim cool | 0.49 | 0.313 | 1.40 |
| Acclim warm | 3.09 | 0.001 * | 2.93 | ||
| OP‐Sus | Acclim cool | 0.29 | 0.387 | 1.12 | |
| Acclim warm | 1.75 | 0.040 ~ | 2.60 |
a Significance following a Bonferroni correction for 12 independent tests is marked with an asterisk, that is, α < 0.004 (< 0.05/12). Significance at α < 0.05 is marked with a tilde.
bThermal factors were calculated as the ratio of larger LD50 to the smaller LD50 estimates for the cool and warm test treatment. The positive sign (+) indicates a larger LD50 in the cool test treatment relative to the warm test treatment.
Post hoc tests for differences in median lethal dose (LD50) values between the OP‐Res and OP‐Sus populations
| Active ingredient | Acclimation treatment | Test treatment |
|
| RF b |
|---|---|---|---|---|---|
| Bifenthrin | Acclim cool | Test cool | 0.35 | 0.363 | 1.21 |
| Test warm | −0.97 | 0.834 | 0.82 | ||
| Acclim warm | Test cool | 1.64 | 0.051 | 1.65 | |
| Test warm | −0.91 | 0.819 | 0.82 | ||
| Chlorpyrifos | Acclim cool | Test cool | 4.53 | <0.001 * | 158.99 |
| Test warm | 3.36 | <0.001 * | 190.21 | ||
| Acclim warm | Test cool | 5.11 | <0.001 * | 156.92 | |
| Test warm | 5.92 | <0.001 * | 139.11 | ||
| Omethoate | Acclim cool | Test cool | 5.24 | <0.001 * | 9.68 |
| Test warm | 3.01 | 0.001 * | 7.75 | ||
| Acclim warm | Test cool | 6.58 | <0.001 * | 5.71 | |
| Test warm | 2.74 | 0.003 * | 5.07 |
aSignificance following a Bonferroni correction for 12 independent tests is marked with an asterisk, that is, α < 0.004 (<0.05/12).
bResistance factors were calculated as the ratio of the resistant OP‐Res population relative to the susceptible OP‐Sus population.